Retractable Technologies, Inc. (NYSE:RVP – Get Free Report)’s share price fell 1.5% during trading on Friday . The company traded as low as $0.6549 and last traded at $0.6602. Approximately 9,202 shares were traded during trading, a decline of 86% from the average daily volume of 63,999 shares. The stock had previously closed at $0.67.
Retractable Technologies Price Performance
The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. The company has a fifty day moving average price of $0.69 and a two-hundred day moving average price of $0.69. The company has a market cap of $19.76 million, a P/E ratio of -1.22 and a beta of 1.22.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of RVP. Eversept Partners LP raised its stake in shares of Retractable Technologies by 59.9% during the 4th quarter. Eversept Partners LP now owns 580,919 shares of the company’s stock worth $449,000 after purchasing an additional 217,604 shares in the last quarter. Renaissance Technologies LLC grew its stake in shares of Retractable Technologies by 4.5% in the fourth quarter. Renaissance Technologies LLC now owns 447,007 shares of the company’s stock valued at $345,000 after buying an additional 19,443 shares in the last quarter. Finally, Susquehanna International Group LLP grew its stake in shares of Retractable Technologies by 135.3% in the third quarter. Susquehanna International Group LLP now owns 54,546 shares of the company’s stock valued at $46,000 after buying an additional 31,362 shares in the last quarter. 7.58% of the stock is currently owned by institutional investors.
About Retractable Technologies
Retractable Technologies, Inc is a U.S.-based medical device company specializing in the design, development and manufacture of safety-engineered injection technologies aimed at reducing needlestick injuries. Headquartered in Little Elm, Texas, Retractable Technologies offers proprietary needle retraction systems that automatically withdraw the needle into the syringe barrel immediately after use, thereby enhancing safety for healthcare workers and patients.
The company’s flagship product, VanishPoint®, features a one-handed, automatic retraction mechanism and is available in multiple configurations, including standard syringes and Luer-lock fittings.
See Also
- Five stocks we like better than Retractable Technologies
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
